


Ask a doctor about a prescription for ATORVASTATIN STADAGEN 80 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Atorvastatina Stadagen 10 mg film-coated tablets EFG
Atorvastatina Stadagen 20 mg film-coated tablets EFG
Atorvastatina Stadagen 40 mg film-coated tablets EFG
Atorvastatina Stadagen 80 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Atorvastatina belongs to a group of medicines known as statins, which are lipid-regulating medicines.
Atorvastatina is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have not worked. If you have a high risk of heart disease, this medicine may also be used to reduce this risk even if your cholesterol levels are normal. During treatment, you should follow a standard low-cholesterol diet.
Do not take Atorvastatina Stadagen
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Atorvastatina Stadagen:
In any of these cases, your doctor may indicate that you should have blood tests before and, possibly, during treatment with this medicine to predict the risk of muscle-related side effects. It is known that the risk of muscle-related side effects (e.g., rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 "Using Atorvastatina Stadagen with other medicines").
Also, inform your doctor or pharmacist if you have persistent muscle weakness, as you may need other tests and medicines to diagnose and treat this condition.
While you are taking this medicine, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. If you have high sugar and fat levels in your blood, are overweight, and have high blood pressure, you may be at risk of developing diabetes.
Using Atorvastatina Stadagen with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
There are some medicines that can affect the proper functioning of atorvastatina or the effects of these medicines may be altered by atorvastatina. This type of interaction can decrease the effect of one or both medicines. Alternatively, this combined use can increase the risk or severity of side effects, including serious muscle damage, known as rhabdomyolysis, described in section 4:
Taking Atorvastatina Stadagen with food and drinks
See section 3 for instructions on how to take Atorvastatina Stadagen. Please note the following:
Grapefruit juice
Do not take more than one or two small glasses of grapefruit juice per day, as large amounts of grapefruit juice can alter the effects of this medicine.
Alcohol
Avoid drinking too much alcohol while taking this medicine. See the details in section 2 "Warnings and precautions".
Pregnancy and breast-feeding
Do not take atorvastatina if you are pregnant, think you may be pregnant, or are planning to become pregnant.
Do not take this medicine if you are of childbearing age unless you take adequate contraceptive measures.
Do not take this medicine if you are breast-feeding your child.
This medicine has not been shown to be safe during pregnancy and breast-feeding.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Normally, this medicine does not affect your ability to drive or use machines. However, do not drive if this medicine affects your ability to drive. Do not use tools or machines if this medicine affects your ability to use them.
Atorvastatina Stadagen contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you should also follow during treatment with this medicine.
The initial dose of this medicine is usually 10 mg once a day in adults and children from 10 years of age. Your doctor may increase it if necessary until you reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of this medicine is 80 mg once a day.
The atorvastatina tablets should be swallowed whole with a glass of water and can be taken at any time of day with or without food. However, try to take your tablet at the same time every day.
Follow the instructions for administration of this medicine indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the duration of treatment with Atorvastatina Stadagen
Ask your doctor if you think the effect of this medicine is too strong or too weak.
If you take more Atorvastatina Stadagen than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 915 620 420, indicating the medicine and the amount ingested.
If you forget to take Atorvastatina Stadagen
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for forgotten doses.
If you stop taking Atorvastatina Stadagen
If you have any other questions about the use of this medicine or want to stop treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you notice any of the following serious side effects or symptoms, stop taking these tablets and inform your doctor immediately or go to the emergency department of the nearest hospital.
Rare: may affect up to 1 in 1,000 people:
Very rare: may affect up to 1 in 10,000 people:
Other possible side effects with this medicine:
Common: may affect up to 1 in 10 people:
Uncommon: may affect up to 1 in 100 people:
Rare: may affect up to 1 in 1,000 people:
Very rare: may affect up to 1 in 10,000 people:
Frequency not known: cannot be estimated from the available data:
Tell your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing.
Possible side effects reported with the use of some statins (medicines of the same class):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, including any possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date that appears on the carton and blister after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
PVC-PE-PVDC/Aluminum blister - Store below 25°C.
Aluminum/polyamide-oriented-aluminum-polyvinyl chloride (PVC) blister - Do not store above 30°C.
HDPE bottle - No special storage conditions required.
Composition of Atorvastatina Stadagen
Each film-coated tablet contains 10 mg of atorvastatin (as atorvastatin calcium trihydrate).
Each film-coated tablet contains 20 mg of atorvastatin (as atorvastatin calcium trihydrate).
Each film-coated tablet contains 40 mg of atorvastatin (as atorvastatin calcium trihydrate).
Each film-coated tablet contains 80 mg of atorvastatin (as atorvastatin calcium trihydrate).
Lactose monohydrate, microcrystalline cellulose, calcium carbonate E170, copovidone, type B crospovidone, sodium croscarmellose, sodium lauryl sulfate, anhydrous colloidal silica, talc, and magnesium stearate.
Coating content: glycerol mono- and di-caprylocaprate, poly(vinyl alcohol), talc, titanium dioxide, and macrogol/poly(vinyl alcohol) grafted copolymer.
Product Appearance and Container Content
Atorvastatina Stadagen 10 mg film-coated tablets: white, round, biconvex tablets with a score on one side and marked with "10" on the other side. The size of each tablet is approximately 7.0 mm.
Atorvastatina Stadagen 20 mg film-coated tablets: white, round, biconvex tablets with a score on one side and marked with "20" on the other side. The size of each tablet is approximately 9.0 mm.
Atorvastatina Stadagen 40 mg film-coated tablets: white, round, biconvex tablets with a score on one side and marked with "40" on the other side. The size of each tablet is approximately 11.0 mm.
Atorvastatina Stadagen 80 mg film-coated tablets: white, round, biconvex tablets with a score on one side and marked with "80" on the other side. The size of each tablet is approximately 13.0 mm.
Atorvastatina Stadagen is available in PVC-PE-PVDC/Aluminum and Aluminum/polyamide-oriented aluminum-polyvinyl chloride (PVC) blisters in packs of 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 90, 98, and 100 film-coated tablets.
Atorvastatina Stadagen is available in HDPE bottles in packs of 98 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Laboratorio STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Manufacturer
Laboratorios Liconsa, S.A.
Polígono Industrial Miralcampo. Avda. Miralcampo, 7
19200 Azuqueca de Henares – Guadalajara
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
United Kingdom: | Atorvastatin 10/20/40/80 mg film-coated tablets |
Denmark: | Atorvastatin "1A Farma" |
Iceland: | Atorvastatin Medical Valley |
Norway: | Atorvastatin Medical Valley |
Spain: | Atorvastatina Stadagen 10/20/40/80 mg film-coated tablets EFG |
Sweden: | Atorvastatin "1A Farma" |
Germany: | Atorvastatin AXiromed 10/20/40/80 mg film-coated tablets |
Netherlands: | Atorvastatine Xiromed 10/20/40/80 mg film-coated tablets |
Date of the last revision of this leaflet:November 2024
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ATORVASTATIN STADAGEN 80 mg FILM-COATED TABLETS in November, 2025 is around 28.79 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ATORVASTATIN STADAGEN 80 mg FILM-COATED TABLETS – subject to medical assessment and local rules.